Moreover, by mining the public data from Human Protein Atlas and TAGC, we demonstrated that low expression of ERβ in melanoma patients across all melanoma subtypes correlate with a poor relapse-free survival, whereas no correlations were observed between survival rates and the expression of ERα or GPER in melanoma patients. The gene discussed is ESR2; the disease is melanoma.